Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Obama Starts Interviewing Supreme Court Candidates
President Obama on Tuesday started interviewing potential Supreme Court nominees, the Wall Street Journal reports. Senior White House adviser David Axelrod on Tuesday said that the administration is looking for a candidate who will give the powerless and disenfranchised people "a fair shake." Conservatives have said that the nominee will inevitably be a "judicial activist" because Obama has said that he wants to nominate a candidate who can use past experience and empathy for the underrepresented populations to help guide court decisions.Obama has started calling Republican senators in an effort to prevent the "bruising battles" past Supreme Court nominations have encountered during the confirmation process, the Journal reports. Obama called Sen. John Cornyn (R-Texas) on Tuesday, which Cornyn said was a "nice gesture." Sen. Tom Coburn (R-Okla.) spoke to Obama last week. Coburn said, "I don"t know that it"s going to be contentious," adding, "A prudent man would say, "I"m going to have a couple of Supreme Court nominees. Maybe I want to defuse the thing, the first one, so I can do what I want to do (with) the second one."" Axelrod said that Obama has spoken to 15 senators from both parties (Weisman/Bendavid, Wall Street Journal, 5/20).

Micrus Endovascular Announces Positive DeltaPaq Microcoil Study Results
Micrus Endovascular Corporation (NASDAQ:MEND) announced that study results presented recently at the 10th Congress of the World Federation of Interventional and Therapeutic Neuroradiology (WFITN) demonstrated that the DeltaPaq™ microcoil"s proprietary design appears to improve the uniformity of coil distribution within a cerebral aneurysm and the degree of microcoil packing in the aneurysm dome and neck, which may reduce the risk of aneurysm recurrence. Bernard R. Bendok, M.D., Assistant Professor of Neurological Surgery and Radiology, Department of Neurological Surgery of Northwestern University Feinberg School of Medicine, and Matthew Gounis, Ph.D., Director of the New England Center for Stroke Research at the University of Massachusetts, served as principal investigators for the Micrus-sponsored in vitro study.
News of the day
El Paso, Texas Planned Parenthood May Shift HIV/AIDS Programs To Other Organizations To Refocus Its Services
The Planned Parenthood Center of El Paso has begun to refocus its services on family planning and women"s health, and likely will shift its HIV/AIDS support programs to other providers that specialize in such services, according to the local agency"s board president, the El Paso Times reports. According to the agency, 56 percent of the center"s budget was earmarked for HIV/AIDS programs, while 30 percent was for family planning and primary health care. Lynn Salas, board president of the El Paso Planned Parenthood, said, "The [Planned Parenthood Federation of America] felt our AIDS/HIV programs had grown so much we were not focusing enough on the core mission, and we began in mid-March to plan the changes we are still working out" (Valdez, El Paso Times, 6/3).
Endocrinology

Developments In Wound Management To Revolutionise Traditional Practices, UK

Infection of surgical wounds is a significant clinical problem which imposes severe demands on healthcare res. The ability to better understand the problems caused by infections and their associated health implications may provide an alternative to traditional wound healing practices. This is just one of the topics set to be discussed at the Recent developments in wound management: intelligent biomaterials to novel antimicrobials one day conference. Hosted by the Royal Pharmaceutical Society of Great Britain (RPSGB), in partnership with the Academy of Pharmaceutical Sciences, the event will take place on Thursday 24 September 2009 at the RPSGB London headquarters. The conference aims to deliver world class research solutions to strategic wound management and will bring delegates up to date with recent developments in this field. Peter Lambert, Professor of Microbiology, at the University of Aston, who will be presenting the key note address "The problem organisms - their , resistance and virulence", said: "Enhanced approaches into ways of improving wound healing practices are urgently required. Understanding the problem organisms of infection cause will improve the effectiveness of skin disinfectants used during surgical procedures." "Devices such as central venous catheters, sutures and dressings can be designed to release antimicrobials and provide protection from associated infection during their lifetime, but this is impractical for long term devices. New strategies are needed to improve the current situation." A major concern is that the widespread use and dependence upon antibiotics and other antimicrobials with medical devices, sutures and dressings will encourage the development of resistance. Evidence for and against will be presented and discussed at the conference. The event has also gathered together speakers with expertise in front line wound management, material science, next generation device development and antimicrobial interventions at the molecular level. Other topics and presentations to be discussed at the conference include novel antimicrobial materials, devices such as drug eluting stents and catheters, along with developments in biomaterial design. The conference is aimed at academic, industrial and regulatory scientists working in biomaterials, synthetic chemistry, natural products, devices and formulation development, in addition to pharmaceutical and medial microbiologists. Delegates who register by Friday 24 July will save up to 10% on the booking fee. To view the programme, go to http://www.rpsgb.org/pdfs/sciconf090924.pdf. Royal Pharmaceutical Society of Great Britain


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009